Last reviewed · How we verify
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Patient with relapsing remitting multiple sclerosis taking avonex are included in this double blind randomized control trial. Simvastatin is compared to placebo. end points of edss , total attack, new enhancing lesion and newt2 lesion in mri is evaluated as end point.
Details
| Lead sponsor | Tehran University of Medical Sciences |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 80 |
| Start date | 2005-04 |
| Completion | 2009-03 |
Conditions
- Relapsing Remitting Multiple Sclerosis
Interventions
- simvastatin
- placebo
Primary outcomes
- attack number — 1 year
Countries
Iran